BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Influenza
,
Pancreas
,
Pharmacogenetics
,
Rosiglitazone
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peptides i
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Monocyte-derived macrophages cultured under various activating conditions
Primary liver hepatocytes after infection with hepatitis B virus
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Transplanted HCmel3 mouse melanomas relapsing post adoptive T-cell (ACT) therapy
Explore Curated Studies Results
Literature
Most Relevant Literature
Inner residues of macrothiolactone in autoinducer peptides I/IV circumvent spontaneous S-to-O acyl t…
Highly Efficient Cyclization Approach of Propargylated Peptides via Gold(I)-Mediated Sequential C-N,…
Changes in RACK1 expression induce defects in nodulation and development in Phaseolus vulgaris.
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is…
From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerab…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I In-Vivo Peptide Applied in the Right Colon
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
A Phase I Study to Evaluate LSALT Peptide
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-…
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ